Arntz H-R, Mochmann H-C
Abteilung für Kardiologie und Pulmologie, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland.
Med Klin Intensivmed Notfmed. 2015 Oct;110(7):537-44. doi: 10.1007/s00063-014-0435-3. Epub 2014 Nov 5.
The prognosis of patients who have been resuscitated after cardiac arrest is still unfavourable and long-term results have only slightly improved. As a consequence, intensivists are frequently confronted with the question of limiting active therapeutic efforts for patients in prolonged coma. The history of the patient and circumstances of the resuscitation are of limited value with regard to reliable decisions.
THERAPEUTIC DECISION-MAKING: Clinical and electrophysiological neurologic techniques as well as biomarkers and diagnostic imaging are, therefore, the basis for prognostication and potential consecutive therapeutic decisions. Sedation, relaxation and particularly therapeutic hypothermia have great influence on the test results. These influences have to be excluded before results can be validated. With regard to therapeutic hypothermia a reliable neurologic evaluation as a basis for limiting treatment is only possible after rewarming. Moreover results of multiple tests should be in agreement before a decision to limit treatment can be made. Finally it must be kept in mind that the absence of unfavourable test results is not proof of a good prognosis.
The decision to limit treatment can not be made on the basis of a single adverse prognostic sign, but requires a comprehensive clinical diagnostic assessment.
心脏骤停后复苏患者的预后仍然不佳,长期结果仅有轻微改善。因此,重症监护医生经常面临为长期昏迷患者限制积极治疗措施的问题。患者的病史和复苏情况对于做出可靠决策的价值有限。
因此,临床和电生理神经学技术以及生物标志物和诊断成像,是预后评估及潜在后续治疗决策的基础。镇静、放松,尤其是治疗性低温对检测结果有很大影响。在结果得到验证之前,必须排除这些影响。对于治疗性低温,只有在复温后才可能进行可靠的神经学评估作为限制治疗的依据。此外,在做出限制治疗的决定之前,多项检测结果应相互一致。最后必须牢记,缺乏不利的检测结果并不证明预后良好。
不能基于单一不良预后迹象做出限制治疗的决定,而需要进行全面的临床诊断评估。